| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |